$1.21
0.82% yesterday
Nasdaq, Sep 26, 10:11 pm CET

Pacific Biosciences of California, Inc. Stock News

Neutral
GlobeNewsWire
5 days ago
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening
Neutral
Seeking Alpha
17 days ago
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 12:20 PM EDT Company Participants Christian Henry - President, CEO & Director Conference Call Participants Yuko Oku - Morgan Stanley, Research Division Presentation Yuko Oku Equity Analyst Hi. My name is Yuko Oku, and I'm on the life science tools and diagnostics tea...
Neutral
GlobeNewsWire
24 days ago
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer
Neutral
Seeking Alpha
about 2 months ago
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Christian O. Henry - President, CEO & Director James R.
Positive
The Motley Fool
about 2 months ago
PACB Sales Up 11%
Neutral
GlobeNewsWire
about 2 months ago
MENLO PARK, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:
Neutral
GlobeNewsWire
about 2 months ago
The most comprehensive, family-based variant dataset ever published will improve variant classification using AI-based tools The most comprehensive, family-based variant dataset ever published will improve variant classification using AI-based tools
Neutral
PRNewsWire
2 months ago
New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of disease BOSTON , July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology business of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a new laboratory test service intended to provide insights into genetic causes of ataxi...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today